FDA Import Refusal 1FX-0760617-2/30002/1 — CIPLA
The FDA refused shipment 1FX-0760617-2/30002/1 from CIPLA (India) on Aug 25, 2026. The refused product falls under Drugs and Biologics — OFLOXACIN (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Aug 25, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61GCA85 OFLOXACIN (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC)
- Charges
- 75